Treace Medical Concepts (TMCI) Shares Outstanding (Weighted Average) (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $64.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 3.08% year-over-year to $64.6 million; the trailing twelve-month figure through Mar 2026 stood at $64.6 million (up 3.08% YoY), and the FY2025 full-year result was $63.3 million, up 1.86% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $64.6 million, up from $63.3 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $64.6 million in Q1 2026 and bottomed at $54.8 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $61.8 million (2024), against an average of $60.5 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) soared 44.84%; it then grew 1.08% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $55.3 million in 2022, then rose by 10.09% to $60.9 million in 2023, then advanced by 2.07% to $62.1 million in 2024, then climbed by 1.86% to $63.3 million in 2025, then advanced by 2.09% to $64.6 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $64.6 million (Q1 2026), $63.3 million (Q4 2025), and $63.1 million (Q3 2025), per Business Quant data.

Peer Comparison